首页> 外文期刊>Journal of anesthesia >Effect of palonosetron on postanesthetic shivering after propofol-remifentanil total intravenous anesthesia
【24h】

Effect of palonosetron on postanesthetic shivering after propofol-remifentanil total intravenous anesthesia

机译:帕洛诺司琼对异丙酚-瑞芬太尼全静脉麻醉后麻醉后颤抖的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: The authors conducted a prospective, randomized, double-blind study to evaluate the anti-shivering efficacy of palonosetron for patients after gynecological laparoscopy under total intravenous propofol-remifentanil anesthesia. Methods: Sixty female patients were randomly assigned to one of two groups and administered palonosetron 0.075 mg (palonosetron group, n = 30) or the same volume of normal saline (control group, n = 30) immediately after anesthesia induction. Anesthesia was induced and maintained with propofol and remifentanil, using a target-controlled infusion device. Esophageal and index finger temperatures were measured immediately after anesthesia induction (baseline) and at 15-min intervals until the end of the surgery. Postanesthetic shivering and side effects were assessed in a postanesthetic care unit. Results: Incidence of shivering was comparable in the control and palonosetron groups (10/30 vs. 8/30, respectively, P = 0.779). No significant intergroup differences were observed between esophageal and index finger temperatures. Compared with baseline values, esophageal temperatures decreased immediately after pneumoperitoneum in the control group and from 30 min after pneumoperitoneum in the palonosetron group. Conclusion: Use of palonosetron (0.075 mg) did not reduce the incidence of postanesthetic shivering after gynecological laparoscopy under propofol-remifentanil anesthesia. Further study including other 5-HT 3 antagonists or male patients would elucidate the effect of palonosetron on shivering after propofol-remifentanil anesthesia.
机译:目的:作者进行了一项前瞻性,随机,双盲研究,以评估帕洛诺司琼对全静脉丙泊酚-瑞芬太尼麻醉下妇科腹腔镜手术后患者的抗颤抖作用。方法:60名女性患者被随机分为两组,并在麻醉诱导后立即给予帕洛诺司琼0.075 mg(帕洛诺司琼组,n = 30)或等体积的生理盐水(对照组,n = 30)。使用靶控输注设备,用异丙酚和瑞芬太尼诱导并维持麻醉。麻醉诱导后(基线)立即测量食道和食指温度,间隔15分钟直至手术结束。在麻醉后护理部门评估麻醉后的发抖和副作用。结果:对照组和帕洛诺司琼组的颤抖发生率相当(分别为10/30与8/30,P = 0.779)。食管和食指温度之间未观察到明显的组间差异。与基线值相比,对照组的气腹温度立即升高,而帕洛诺司琼组的气腹温度从30分钟开始降低。结论:在丙泊酚-瑞芬太尼麻醉下,妇科腹腔镜检查后使用帕洛诺司琼(0.075 mg)不能降低麻醉后发抖的发生率。进一步的研究(包括其他5-HT 3拮抗剂或男性患者)将阐明帕洛诺司琼对丙泊酚-瑞芬太尼麻醉后发抖的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号